University of Thessaly (UTH)
Εύρος κατανομής ερυθρών αιμοσφαιρίων (RDW) σε ασθενείς με καρδιακή ανεπάρκεια και σακχαρώδη διαβήτη: ο ρόλος των αναστολέων των συμμεταφορέων γλυκόζης-νατρίου (SGLT-2i)
Abstract
dc:descriptionDiabetes mellitus is one of the most important risk factors for developing heart failure and vice versa. A new class of antidiabetic drugs that has been associated with favorable cardiovascular outcomes in patients with diabetes mellitus and heart failure is the Sodium-glucose co-transporter 2 inhibitors (SGLT2i). Although we do not know the exact mechanisms through which they exert their beneficial effects in these patients, recent studies indicate that one of the main mechanisms is the stimulation of hematopoiesis through an early increase in endogenous erythropoietin production resulting in an increase in hematocrit. Red blood cell distribution range (RDW) is a simple CBC parameter that reflects the heterogeneity of red blood cell size known as anisocytosis. Erythropoietin is a hormone that has been associated with pathophysiological pathways of increased RDW values. The purpose of the present mechanistic study was to examine the effect of SGLT2i administration on erythrocyte size (RDW) in patients with heart failure and diabetes mellitus. For this reason, a prospective single-center study was conducted in which 110 patients with heart failure and diabetes mellitus were included. Patients were randomly divided into two groups with a ratio of 1:1 namely those who were started on dapagliflozin 10 mg daily in addition to their existing antidiabetic treatment and those who were not made any modification of their antidiabetic treatment (control group). Inclusion criteria for patients in the study were to be over 18 years of age, to have individual reminder of type 2 diabetes mellitus and heart failure with at least one hospitalization in the last six months due to deregulation of heart failure. Patient evaluation included clinical assessment, laboratory blood tests and echocardiographic study and was performed at baseline, six and twelve months. Data were modeled using linear mixed models with the RDW index as the dependent variable. In order to find factors independently associated with prognosis, multiple logistic regression analysis was performed with 1-year mortality or readmission for heart failure as the dependent variable. In the SGLT2i (dapagliflozin) group, an increase in RDW values was observed at both six and twelve months (p<0.001 for the entire comparison period), whereas there was no significant change in the control group. Increasing RDW values were positively correlated with erythropoietin values, while there was a negative correlation with ferritin and folic acid values (p < 0.005 for all). Baseline RDW values were statistically significantly associated with 1-year mortality or rehospitalization for HF after adjustment for group type (SGLT2i vs control group), age, sex, smoking, and body mass index during the initial assessment. In conclusion RDW values increased over time in patients with heart failure and diabetes mellitus in patients treated with SGLT2i (dapagliflozin). This increase in RDW values in these patients may be due to the induction of the hematopoietic process by dapagliflozin. Finally, initial RDW values were independently associated with outcome in patients with heart failure and diabetes mellitus.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Katsiadas, Nikolaos
- Κατσιάδας, Νικόλαος
Subjects
dc:subject × 14- Εύρος κατανομής ερυθρών αιμοσφαιρίων (RDW)
- Καρδιακή ανεπάρκεια
- Σακχαρώδης διαβήτης
- Αναστολείς συμμεταφορέων γλυκόζης νατρίου 2
- Sodium glucose co-transporter-2 inhibitors
- Red blood cell distribution width
- Heart failure
- Diabetes mellitus
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Καρδιολογία και Καρδιοαγγειακά νοσήματα
- Clinical Medicine
- Medical and Health Sciences
- Cardiology and Cardiovascular Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/54074